MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lansea.2025.100581

Медицинская библиотека · The Lancet regional health. Southeast Asia · 2025

Modeling the initial impact and predicted future benefits of TCV from two Pakistani provinces.

Kraay Alicia N M, Yousafzai Mohammad T, Qureshi Sonia, Gauld Jillian, Qamar Farah N

СтатьяПеревод в очереди

Аннотация

BACKGROUND

While trials have demonstrated high efficacy of typhoid conjugate vaccine (TCV), data on effectiveness are limited. We report initial impacts and predict future benefits of TCV from two provinces in Pakistan.

METHODS

We used blood culture-confirmed typhoid cases from the Surveillance for Enteric Fever in Asia Project (SEAP) and Impact assessment of Typhoid conjugate vaccine following a catch-up campaign and introduction in Routine Immunization Program of Pakistan (ITRIPP) to estimate the population-level impact of vaccination (2018-2023). We used regression models to estimate initial impacts and an agent-based model to predict future benefits.

FINDINGS: In Sindh, typhoid incidence was higher and cases occurred in younger children compared with Punjab. TCV reduced incidence by 48.9% in Sindh (95% CI: 47.3-50.3%) and 66.2% in Punjab (95% CI: 64.7%, 67.6%) over the first 2 years after vaccine rollout but declined each year. In Sindh, waning was quicker and models predicted that population incidence would stabilize near pre-vaccine levels in 2024. An additional campaign could provide short-term, but not long-term, benefits. In contrast, in Punjab, incidence is projected to remain low for several years, and the catch-up campaign with routine immunization at 9 months of age may be sufficient. However, follow up data from Punjab are needed to better characterize waning immunity.

INTERPRETATION: TCV has reduced incidence in Pakistan, but protection varies by site. Routine immunization at 9 months of age along with a catch-up campaign may be sufficient to control incidence in settings with moderate transmission. However, in settings with particularly high incidence and/or short duration of protection, alternative strategies to reduce the force of infection may be needed.

FUNDING: Bill & Melinda Gates Foundation.

Для цитирования: Kraay Alicia N M, Yousafzai Mohammad T, Qureshi Sonia, Gauld Jillian, Qamar Farah N. Modeling the initial impact and predicted future benefits of TCV from two Pakistani provinces.. The Lancet regional health. Southeast Asia. 2025. DOI: 10.1016/j.lansea.2025.100581.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.